Typicality: | 0.523 |
Saliency: | 0.259 |
in the annual exacerbation rate ratio | 10 | other |
statistically | 6 | manner |
compared with placebo | 5 | other |
subject → have → significant reduction | 15 |
subject → have → significant reductions | 7 |
negative | neutral | positive |
0.032 | 0.618 | 0.350 |
Raw frequency | 22 |
Normalized frequency | 0.259 |
Modifier score | 1.000 |
Perplexity | 60.477 |